Feasibility of switching anti-tumour necrosis factor-alpha therapy in patients with rheumatois arthritis

被引：0
|
作者：
Walsh, C. A. E. [1 ]
Minnock, P. [1 ]
Slattery, C. [1 ]
Kennedy, N. [1 ]
Veale, D. J. [1 ]
Bresnihan, B. [1 ]
FitzGerald, O. [1 ]
机构：
[1] St Vincents Univ Hosp, Dept Rheumatol, Dublin, Ireland
来源：
RHEUMATOLOGY | 2006年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：I52 / I52
页数：1
相关论文
共 50 条
  • [1] SMOKING IMPACT IN THE EFFECTIVENESS OF ANTI-TUMOUR NECROSIS FACTOR-ALPHA THERAPY IN PORTUGUESE SPONDYLOARTHRITIS PATIENTS
    Aguiar, F.
    Rosa-Goncalves, D.
    Fonseca, R.
    Vieira, R.
    Madureira, P.
    Bernardo, A.
    Bernardes, M.
    Brito, I.
    Costa, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1146 - 1146
  • [2] What is the mechanism of action of anti-tumour necrosis factor-alpha antibody in rheumatoid arthritis?
    Feldmann, M
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1996, 111 (04) : 362 - 365
  • [3] A new adverse effect with anti-tumour necrosis factor-alpha?
    Theophile, H
    Richez, C
    Barry, MB
    Schaeverbeke, T
    Moore, N
    Haramburu, F
    DRUG SAFETY, 2005, 28 (10) : 945 - 945
  • [4] Anti-tumour necrosis factor-alpha therapy over conventional therapy improves endothelial function in adults with rheumatoid arthritis
    William Bilsborough
    Helen Keen
    Andrew Taylor
    Gerard J. O’Driscoll
    Leonard Arnolda
    Daniel J. Green
    Rheumatology International, 2006, 26 : 1125 - 1131
  • [5] Anti-tumour necrosis factor-alpha therapy over conventional therapy improves endothelial function in adults with rheumatoid arthritis
    Bilsborough, William
    Keen, Helen
    Taylor, Andrew
    O'Driscoll, Gerard J.
    Arnolda, Leonard
    Green, Daniel J.
    RHEUMATOLOGY INTERNATIONAL, 2006, 26 (12) : 1125 - 1131
  • [6] The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor
    Harrold, Leslie R.
    Reed, George W.
    Kremer, Joel M.
    Curtis, Jeffrey R.
    Solomon, Daniel H.
    Hochberg, Marc C.
    Greenberg, Jeffrey D.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (02) : 430 - 436
  • [7] Haemophagocytic lymphohistiocytosis due to leishmaniasis following anti-tumour necrosis factor-alpha therapy
    Estabrooks, Kristen L.
    De Silva, Keshani
    Survela, Lesley
    Stevenson, William S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 203 (04) : 497 - 498
  • [8] Peripheral blood lymphocytes from patients with rheumatoid arthritis are differentially sensitive to apoptosis induced by anti-tumour necrosis factor-alpha therapy
    Coury, F.
    Ferraro-Peyret, C.
    Le Cam, S.
    Guerin, S.
    Tebib, J.
    Sibilia, J.
    Bienvenu, J.
    Fabien, N.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (02) : 234 - 239
  • [9] Clinical trial outcome of anti-tumour necrosis factor alpha therapy in rheumatic arthritis
    Choy, E
    CYTOKINE, 2004, 28 (4-5) : 158 - 161
  • [10] Anti-tumour necrosis factor alpha therapy normalises fibrinolysis impairment in patients with active rheumatoid arthritis
    Ingegnoli, F.
    Fantini, F.
    Griffini, S.
    Soldi, A.
    Meroni, P. L.
    Cugno, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : 254 - 257
12345